IN THE PAST, measles has been an almost universal childhood disease. Although many consider it to be rather benign, it sometimes has serious complications, such as encephalitis, otitis, and pneumonia.
Before vaccines were widely used. this disease represented a major public health problem in the United States; an estimated 4 million cases of measles, 4,000 cases of measles encephalitis, and 400 deaths occurred each year.
The isolation of measles virus in 1954 (1) led to the development of effective vaccines. With the licensure of the live virus vaccine in 1963, a means of protecting susceptible persons in the population through vaccination became available.
When in 1966 it became apparent that measles could be eradicated in the United States, private medicine and Federal, State, and local governments collaborated on a major program to eliminate the disease (2, 3) . This nationwide effort has had an unmistakable effect on the incidence of measles. In 1968 the estimated number of measles cases was 250,000 or about 6 AU the authors are with the National Communicable Disease Center, Public Health Service, Atlaa, Ga. Mr. Axnick Our objective is to quantify the national impact of immunization against measles. The benefits derived from immunization can be translated into savings in school days, hospital days, dollars, morbidity, and mortality. This kind of information is particularly relevant today, when decision makers in the $50-billion health services industry-now one of the largest and most sensitive segments of the national economy-are all too often forced to base decisions on seriously inadequate data.
Methodology
For the period 1963 through 1968, we estimated (a) costs that the nation would have sustained without immunization against measles and (b) the actual costs of measles. The difference between these costs is the immunization benefit; that is, (a) estimated measles costs without immunization minus (b) actual measles costs equals (c) benefits due to immunization.
To illustrate these ideas, consider measles deaths. Suppose that in a certain period X number of persons would have died of measles had there been no immunizations. Assume in addition that only Y persons died of measles during this time. The benefit due to measles immunization is therefore X minus Y, or Z lives saved.
When determining the net economic or dollar savings due to immunization, the cost of immunization itself must be considered. In other words, net dollar savings equal dollar benefits minus dollar costs of immunization. This relationship between costs, benefits, and net savings is depicted in figure 1 .
Definition of Terms
The costs of measles must be more carefully described. They can be measured in terms of "health" and "resources" and then translated into dollars.
The items that comprise health and resource costs include morbidity, mortality, incidence of mental retardation, number of lost days in the hospital, and number of lost workdays and schooldays. Not included are important but difficult-to-measure costs such as misery and unhappiness. A few of the listed costs require minor elaboration: One measles death occurs for every 10,000 cases and is usually attribu- We assumed that half the number of pameasles each year in the United States. This tients who were not hospitalized were attended number of cases must have occurred to explain by physicians-half of these in the physician's the 90 to 95 percent level of natural immunity office and half in the patients' homes. Unpubthat the U.S. population achieved regularly by lished data from the Division of Health Interyoung adulthood (4) . Presumably then, during view Statistics, National Center for Health 1963-68 the average annual incidence would Statistics, indicated that 51 percent of measles have been about 4 million cases if measles vac-patients were medically attended in 1964 and cine had not been used. We also considered the 65 percent in 1965. past periodicity of measles ( fig. 2 ). Estimates Physicians' charges for house calls, office of the actual incidence of measles are based on visits, and hospital visits are based on data from projections from reported morbidity and mor-the Consumer Price Indexes (11) published by tality statistics for measles.
the Bureau of Labor Statistics (BLS). In 1962, For every 100,000 cases of measles, 100 cases the -average charge for an office visit was $5 and of measles encephalitis can 'be expected to occur. for a house call $8 (12) . We adjusted these figTen of the 100 encephalitis patients will die ures by the BLS Physician Fee Index (11) to and 33 will be mentally retarded or have other reflect rising medical costs for subsequent years central nervous system damage (4). Long-term A comment about the Physician Fee Index intensive care or institutionalization is assumed and other BLS indexes on the prices of medical for this group. In addition, according to unpub-care may be in order at this point. Some econolished data of the Immunization Branch, Na. mists believe that the actual increase in the cost of medical services has been even more dramatic than BLS surveys indicate. They contend that BLS probably underestimates increases in prices of medical goods and services included in its index and that these goods and services may not 'be truly representative of medical care today (13) . Therefore, our adjustments in the rising costs of medical care are likely to be conservative.
Estimates of physicians' charges to patients who were hospitalized with nonencephalitic acute measles are based on the assumption that the typical patient had an initial limited hospital examination and thereafter saw his physician daily. The 1968 estimate was based on the change from 1967 to 1968 in the BLS index of Hospital Room Rates. The daily expense figure was then multiplied by the number of patient days. We assumed that the cost of gamma globulin for measles contacts would have been $276 per 1,000 cases with no immunization program (6) .
The cost, in excess of normal maintenance cost, of custodial care for the institutionalized has been estimated at $3,000 per year per patient and is assumed to recur each year for the next 40 The dollar loss due to mortality-an indirect economic cost-is comprised of current and future earnings, representing the value of goods and services, foregone as a result of the premature death of persons who otherwise would have been expected to join the labor force. As explained, since losses reach into future years, the proper way to evaluate them is to discount them at 4 percent. We followed the outline described by Rice for computations (10) . Factors such as distribution of measles deaths by different age and sex groups, participation rates in the labor force, earnings, and life expectancy were considered.
For those who would never join the labor force because of mental retardation, the economic value of the losses involved were calculated as described previously. The value of time lost from work because of measles in the adult population takes into account the distribution of measles morbidity and earnings in that group (6-10 and unpublished data from Wilder).
C08t of immuniation. We estimated the public and private cost of immunizing persons-in the public sector, this oost includes promotion expenses as well as the cost of producing, distributing, and administering vaccine-at $3 per dose of vaccine distributed. Multiplying this figure by the number of doses distributed produces the estimated cost of immunizing persons (umpublished data of the Immunization Branch, NCDC).
Results and Discussion
A sharp decline in estimated incidence of measles ( fig. 2) shows most directly the salutary effect of immunization. The estimated incidence dropped steadily from u 1963-64 level of about 4 million cases to a low of one quarter of a million cases in 1968. Reduction in other health and resource costs (tables 1 and 2) was equally dramatic.
Results of the study clearly indicate that the immunization program, in addition to improving health in the nation, released substantial medical, educational, and economic resources for other uses. The medical resources included more than half a million hospital days and more than 5 million physician visits. Among the savings in educational resources were 32 million schooldays; and because the program prevented 3,244 cases of retardation, it saved the large amounts of money associated with special schooling for the mentally subnormal. The immunization program also saved the nation 1.6 million workdays and, by preventing premature deaths and mental retardation, insured that more than 4,000 persons would be able to lead about 291,000 additional years of normal and productive life.
Significantly, about nine-tenths of the reduction in incidence was during 1966-68, the period of intensive national effort to eradicate measles by immunization. During this time many of the urban poor who could not afford to pay for the vaccine were immn ized (17) .
As with reduction of incidence, the savings in lives, cases of mental retardation, hospital days, and school days (table 1) were six times greater in the second 3-year period (1966-68) than in the first . And the net economic savings jumped 2,000 percent between 000 2,389, 000 1, 624, 000 Schooldays the end of the first 3-year period and the end of the second (fig. 3) .
The fact that benefits appear to have increased with time cannot be completely ascribed to a more efficient use of resources: the proportion of immune persons in a population depends partly on the number of immunizations given in the past. As this proportion increases, -the probability of a measles outbreak among a susceptible population decreases because of the diminished number of persons capable of spreading infection. In this way, the protective immunity that inoculation against measles confers on susceptible populations increases as time passes. The benefits therefore would also be expected to increase with time.
The relative size of indirect economic benefits is a salient aspect of the statistics on economic benefits. The indirect costs (table 3) constitute almost half (48 percent) of the total economic benefits. These costs are usually significant but nevertheless have been frequently overlooked as a part of the costs or benefits associated with a certain disease or control measure.
Possibly the most important aspect of the statistics is that they make explicit the full magnitude of the harm that can be done by a "mild" children's disease. For a long time, a bout with measles was regarded by many physicians as an unpleasant but not very dangerous part of life (18) . They probably did not con- 36, 808 Grand total -1, 278, 657 747,114 531, 543 sider that since the disease struck so many persons it did great damage and therefore would make an especially good candidate for eradication. Measles has been a good candidate for an eradication effort. The results of systematic studies like this one should be used in the future not only to determine whether success or failure characterizes certain programs but also to help an administrator identify and evaluate the various ramifications of the options open to him.
Summary
The inmunization effort against measles in the United States was initiated in 1963. It has resulted in a sharp decrease in incidence of the disease-from 4 million cases in 1963 to onequarter of a million cases in 1968-and in associated costs.
A study by researchers of the National Communicable Disease Center shows that during the years 1963 through 1968 the immunization effort is estimated to have averted 9.7 million acute cases of measles and 3,244 cases of mental retardation. It also is estimated to have saved 973 lives, 555,000 hospital days, 291,000 years of normal life, more than 1.6 million workdays, 32 million schooldays, and $423 million.
About nine-tenths of the savings in each of these categories has been realized in the last 3 year-the period of intensive national effort to eradicate measles.
